Quarterly report which provides a continuing view of a company`s financial position
(WorldNews Environment)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________________ to ______________________ Commission File Number: 001-38085 Ovid Therapeutics Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 46-5270895 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 1460 Broadway, Suite 15044 New York, New York 10036 (Address of...